Functional Effects of Autoantibodies

The Autoimmune Diseases, Fourth Edition

Volumn , Issue , 2006, Pages 217-236

  Waterman, Sally A ^a   Jackson, Michael W ^a   Gordon, Tom P ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70549109515     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012595961-2/50020-2     Document Type: Chapter

References (213)

1. D.D. Adams and H.D. Purves (1956) The assessment of thyroid function by tracer tests with radioactive iodine. N. Z. Med. J. 55 36-41.
2. R.R. Almon, C.G. Andrew and S.H. Appel (1974) Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors. Science 186 55-57.
3. P.R. Andjus, L. Khiroug, A. Nistri and E. Cherubini (1996) ALS IgGs suppress [Ca2+]i rise through P/Q-type calcium channels in central neurones in culture. Neuroreport 7 1914-1916.
4. P.R. Andjus, Z. Stevic-Marinkovic and E. Cherubini (1997) Immunoglobulins from motoneurone disease patients enhance glutamate release from rat hippocampal neurones in culture. J. Physiol. 504 103-112.
5. A.P. Andonopoulos, J. Christodoulou, C. Ballas, A. Bounas and D. Alexopoulos (1998) Autonomic cardiovascular neuropathy in Sjögren's syndrome. A controlled study. J. Rheumatol. 25 2385-2388.
6. P.I. Andrews, M.A. Dichter, S.F. Berkovic, M.R. Newton and J.O. McNamara (1996) Plasmapheresis in Rasmussen's encephalitis. Neurology 46 242-246.
7. S.H. Appel, R.R. Almon and N. Levy (1975) Acetylcholine receptor antibodies in myasthenia gravis. N. Engl. J. Med. 293 760-761.
8. S.H. Appel, J.I. Engelhardt, J. Garcia and E. Stefani (1991) Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc. Natl. Acad. Sci. USA 88 647-651.
9. M. Atger, M. Misrahi, J. Young, A. Jolivet, J. Orgiazzi, G. Schaison and E. Milgrom (1999) Autoantibodies interacting with purified native thyrotropin receptor. Eur. J. Biochem. 265 1022-1031.
10. S. Bacman, C. Perez Leiros, L. Sterin-Borda, O. Hubscher, R. Arana and E. Borda (1998) Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest. Ophthalmol. Vis. Sci. 39 151-156.
11. S. Bacman, L. Sterin-Borda, J.J. Camusso, R. Arana, O. Hubscher and E. Borda (1996) Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin. Exp. Immunol. 104 454-459.
12. B. Balestra, M. Moretti, R. Longhi, R. Mantegazza, F. Clementi and C. Gotti (2000) Antibodies against neuronal nicotinic receptor subtypes in neurological disorders. J. Neuroimmunol. 102 89-97.
13. P.A. Barber, N.E. Anderson and A. Vincet (2000) Morvan's syndrome associated with voltage-gated K+ channel antibodies. Neurology 54 771-772.
14. M. Benatar (2000) Neurological potassium channelopathies. Q. J. Med. 93 787-797.
15. D. Beroukas, R. Goodfellow, J. Hiscock, R. Jonsson, T.P. Gordon and S.A. Waterman (2002) Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren's syndrome. Lab. Invest. 82 203-210.
16. E. Borda, C.P. Leiros, S. Bacman, A. Berra and L. Sterin-Borda (1999) Sjögren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation. Int. J. Cardiol. 70 23-32.
17. M. Boutjdir (2000) Molecular and ionic basis of congenital complete heart block. Trends Cardiovasc. Med. 10 114-122.
18. M. Boutjdir, L. Chen, Z.H. Zhang, C.E. Tseng, F. DiDonato, W. Rashbaum, A. Morris, N. el-Sherif and J.P. Buyon (1997) Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ. Res. 80 354-362.
19. S.M. Brierley, K. Nichols, D.J. Grasby and S.A. Waterman (2001) Neural mechanisms underlying migrating motor complex formation in mouse isolated colon. Br. J. Pharmacol. 132 507-517.
20. M.R. Bristow, R. Ginsburg, W. Minobe, R.S. Cubicciotti, W.S. Sageman, K. Lurie, M.E. Billingham, D.C. Harrison and E.B. Stinson (1982) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 307 205-211.
21. B. Buchwald, R. Ahangari, A. Weishaupt and K.V. Toyka (2002) Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome. Ann. Neurol. 51 673-680.
22. B. Buchwald, A. Weishaupt, K.V. Toyka and J. Dudel (1998) Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. Eur. J. Neurosci. 10 281-290.
23. C. Buckley, J. Oger, L. Clover, E. Tuzun, K. Carpenter, M. Jackson and A. Vincent (2001) Potassium channel antibodies in two patients with reversible limiic encephalitis. Ann. Neurol. 50 73-78.
24. J.P. Buyon (1996) Neonatal lupus. Curr. Opin. Rheumatol. 8 485-490.
25. J.P. Buyon, R. Clancy, F. Di Donato, M.E. Miranda-Carus, A.D. Askanase, J. Garcia, Y. Qu, K. Hu, Y. Yue, E.K. Chan and M. Boutjdir (2002) Cardiac 5-HT(4) serotoninergic receptors, 52kD SSA/Ro and autoimmune-associated congenital heart block. J. Autoimmun. 19 79-86.
26. M.V. Catania, M. Bellomo, V. Di Giorgi-Gerevini, G. Seminara, R. Giuffrida, R. Romeo, A. De Blasi and F. Nicoletti (2001) Endogenous activation of group-I metabotropic glutamate receptors is required for differentiation and survival of cerebellar Purkinje cells. J. Neurosci. 21 7664-7673.
27. D. Cavill, S. Waterman and T.P. Gordon (2002) Failure to detect antibodies to the second extracellular loop of the serotonin 5-HT4 receptor in systemic lupus erythematosus and primary Sjögren's syndrome. Lupus 11 197-198.
28. D. Cavill, S.A. Waterman and T.P. Gordon (2002) Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sjögren's syndrome. J. Rheumatol. 29 1342-1344.
29. D. Cavill, S.A. Waterman and T.P. Gordon (2003) Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission. Arthritis Rheum. 48 3597-3602.
30. D. Cavill, S.A. Waterman and T.P. Gordon (2004) Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome. Scand. J. Immunol. 59 261-266.
31. P.A. Chiale, I. Ferrari, E. Mahler, M.A. Vallazza, M.V. Elizari, M.B. Rosenbaum and M.J. Levin (2001) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103 1765-1771.
32. T. Christ, E. Wettwer, D. Dobrev, E. Adolph, M. Knaut, G. Wallukat and U. Ravens (2001) Autoantibodies against the betal adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J. Mol. Cell. Cardiol. 33 1515-1525.
33. P.D. Clouston, C.B. Saper, T. Arbizu, I. Johnston, B. Lang, J. Newsom-Davis and J.B. Posner (1992) Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 42 1944-1950.
34. M. Coesmans, P.A. Smith, D.J. Linden, R. Shigemoto, T. Hirano, Y. Yamakawa, A.M. van Alphen, C. Luo, J.N. van der Geest, J.M. Kros, C.A. Gaillard, M.A. Frens and C.I. de Zeeuw (2003) Mechanisms underlying cerebellar motor deficits due to mGluR1-autibodies. Ann. Neurol. 53 325-336.
35. M.C. Dalakas, D.P. Stein, C. Otero, E. Sekul, E.J. Cupler and S. McCrosky (1994) Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy. Arch. Neurol. 51 861-864.
36. S.F. de Oliveira, R.C. Pedrosa, J.H. Nascimento, A.C. Campos de Carvalho and M.O. Masuda (1997) Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation 96 2031-2037.
37. L.A. DeGiorgio, K.N. Konstantinov, S.C. Lee, J.A. Hardin, B.T. Volpe and B. Diamond (2001) A subset of lupus anti-DNA antibodies crossreacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7 1189-1193.
38. O. Delbono, V. Magnelli, T. Sawada, R.G. Smith, S.H. Appel and E. Stefani (1993) Fab fragments from amyotrophic lateral sclerosis IgG affect calcium channels of skeletal muscle. Am. J. Physiol. 264 C537-C543.
39. A.R. Denniss, J.D. Marsh, R.J. Quigg, J.B. Gordon and W.S. Colucci (1989) Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts. Circulation 79 1028-1034.
40. R. Dingledine, K. Borges, D. Bowie and S.F. Traynelis (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51 7-61.
41. D.B. Drachman (2003) Autonomic “myasthenia”: the case for an autoimmune pathogenesis. J. Clin. Invest. 111 797-799.
42. J.M. Edwardson and P.G. Szekeres (1999) Endocytosis-and recycling of muscarinic receptors. Life Sci 64 487-494.
43. P. Eftekhari, J.C. Roegel, F. Lezoualc'h, R. Fischmeister, J.L. Imbs and J. Hoebeke (2001) Induction of neonatal lupus in pups of mice immunized with synthetic peptides derived from amino acid sequences of the serotoninergic 5-HT4 receptor. Eur. J. Immunol. 31 573-579.
44. P. Eftekhari, L. Salle, F. Lezoualc'h, J. Mialet, M. Gastineau, J.P. Briand, D.A. Isenberg, G.J. Fournie, J. Argibay, R. Fischmeister, S. Muller and J. Hoebeke (2000) Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur. J. Immunol. 30 2782-2790.
45. R. Elies, L.X. Fu, P. Eftekhari, G. Wallukat, W. Schulze, C. Granier, A. Hjalmarson and J. Hoebeke (1998) Immunochemical and functional characterization of an agonist-like monoclonal antibody against the M2 acetylcholine receptor. Eur. J. Biochem. 251 659-666.
46. A. Evoli, P.A. Tonali, L. Padua, M.L. Monaco, F. Scuderi, A.P. Batocchi, M. Marino and E. Bartoccioni (2003) Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126 2304-2311.
47. W. Fang, M.W. Jackson, V. Maughan, D. Cavill, A.J. Smith, S.A. Waterman and T.P. Gordon (2004) Passive transfer of Sjögren's sydrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum 50 3637-3645.
48. S.S. Ferguson (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53 1-24.
49. C.F. Fletcher, A. Tottene, V.A. Lennon, S.M. Wilson, S.J. Dubel, R. Paylor, D.A. Hosford, L. Tessarollo, M.W. McEnery, D. Pietrobon, N.G. Copeland and N.A. Jenkins (2001) Dystonia and cerebellar atrophy in Cacnala null mice lacking P/Q calcium channel activity. FASEB J. 15 1288-1290.
50. M.T. Flink and W.D. Atchison (2002) Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission. J. Physiol. 543 567-576.
51. S.A. Fratantoni, G. Weisz, A.M. Pardal, R.C. Reisin and O.D. Uchitel (2000) Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker. Muscle Nerve 23 543-550.
52. L.X. Fu, Y. Magnusson, C.H. Bergh, J.A. Lilieqvist, F. Waagstein, A. Hjalmarson and J. Hoebeke (1993) Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 91 1964-1968.
53. M.L. Fu (1995) Anti-peptide antibodies against an autoimmune epitope on human muscarinic receptor mimic functional autoantibodies against the same epitope in patients with idiopathic dilated cardiomyopathy. Eur. Heart. J. 16(Suppl O), 89-91.
54. M.L. Fu, H. Herlitz, W. Schulze, G. Wallukat, P. Micke, P. Eftekhari, K.G. Sjogren, A. Hjalmarson, W. Muller-Esterl and J. Hoebeke (2000) Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J. Hypertens 18 945-953.
55. M.L. Fu, P.S. Leung, G. Wallukat, G. Bergstrom, H. Fu, W. Schulze and H. Herlitz (1999) Agonist-like activity of antibodies to angiotensin II receptor subtype I (ATI) from rats immunized with AT1 receptor peptide. Blood Press. 8 317-324.
56. M.L. Fu, W. Schulze, G. Wallukat, A. Hjalmarson and J. Hoebeke (1995) Functional epitope analysis of the second extracellular loop of the human heart muscarinic acetylcholine receptor. J. Mol. Cell. Cardiol. 27 427-436.
57. M.L. Fu, W. Schulze, G. Wallukat, A. Hjalmarson and J. Hoebeke (1996) A synthetic peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits. Clin. Immunol. Immunopathol. 78 203-207.
58. T. Fukuda, M. Motomura, Y. Nakao, H. Shiraishi, T. Yoshimura, K. Iwanaga, M. Tsujihata and K. Eguchi (2003) Reduction of P/Q-type calcium channels in the postmortemm cerebellum of paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome. Ann. Neurol. 53 21-28.
59. H. Fukunaga, A.G. Engel, B. Lang, J. Newsom-Davis and A. Vincent (1983) Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc. Natl. Acad. Sci. USA 80 7636-7640.
60. T. Fukuoka, A.G. Engel, B. Lang, J. Newsom-Davis, C. Prior and D.W. Wray (1987) Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones. Ann. Neurol. 22 193-199.
61. L.C. Gahring, S.W. Rogers and R.E. Twyman (1997) Autoantibodies to glutamate receptor subunit GluR2 in nonfamilial olivopontocerebellar degeneration. Neurology 48 494-500.
62. L.C. Gahring, R.E. Twyman, J.E. Greenlee and S.W. Roger (1995) Autoantibodies to neuronal glutamate receptors in patients with paraneoplastic neurodegenerative syndrome enhance receptor activation. Mol. Med. 1 245-253.
63. S. Garcia, J.H. Nasctmento, E. Bonfa, R. Levy, S.F. Oliveira, A.V. Tavares and A.C. de Carvalho (1994) Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J. Clin. Invest. 93 718-724.
64. J.C. Goin, E. Borda, C.P. Leiros, R. Storino and L. Sterin-Borda (1994) Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J. Auton. Nerv. Syst. 47 45-52.
65. J.C. Goin, C.P. Leiros, E. Borda and L. Sterin-Borda (1997) Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J. 11 77-83.
66. J.C. Goin, C. Perez Leiros, E. Borda and L. Sterin-Borda (1994) Modification of cholinergic-mediated cellular transmembrane signals by the interaction of human chagasic IgG with cardiac muscarinic receptors. Neuroimmunomodulation 1 284-291.
67. F. Golblatt, T.P. Gordon and S.A. Waterman (2002) Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 123 1144-1150.
68. T.P. Gordon, A.I. Bolstad, M. Rischmueller, R. Jonsson and S.A. Waterman (2001) Autoantibodies in primary Sjogren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 34 123-132.
69. C. Grassi, V. Magnelli, V. Carabelli, E. Sher and E. Carbone (1994) Inhibition of low- and high-threshold Ca2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs. Neurosci. Lett. 181 50-56.
70. C. Grassi, M. Martire, D. Altobelli, G.B. Azzena and P. Preziosi (1999) Characterization of Ca(2+)-channels responsible for K(+)-evoked [(3)H]norepinephrine release from rat brain cortex synaptosomes and their response to amyotrophic lateral sclerosis IgGs. Exp. Neurol. 159 520-527.
71. F. Graus, B. Lang, P. Pozo-Rosich, A. Saiz, R. Casamitjana and A. Vincent (2002) P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59 764-766.
72. B. Gudbjornsson, H. Hedenstrom, G. Stalenheim and R. Hallgren (1991) Bronchial hyperresponsiveness to methacholine in patients with primary Sjogren's syndrome. Ann. Rheum. Dis. 50 36-40.
73. I.K. Hart, P. Maddison, J. Newsom-Davis, A. Vincent and K.R. Mills (2002) Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125 1887-1895.
74. I.K. Hart, C. Waters, A. Vincent, C. Newland, D. Beeson, O. Pongs, C. Morris and J. Newsom-Davis (1997) Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann. Neurol. 41 238-246.
75. X.P. He, M.S. Patel, K.D. Whitney, S. Janumpalli, A.J. Tenner and J.O. McNamara (1998) Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron 20 153-163.
76. T.E. Hebert, S. Moffett, J.P. Morello, T.P. Loisel, D.G. Bichet, C. Barret and M. Bouvier (1996) A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol. Chem. 271 16384-16392.
77. S.M. Heilbrunn, P. Shah, M.R. Bristow, H.A. Valantine, R. Ginsburg and M.B. Fowler (1989) Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 79 483-490.
78. C.C. Hernandez, L.C. Barcellos, L.E. Gimenez, R.A. Cabarcas, S. Garcia, R.C. Pedrosa, J.H. Nascimento, E. Kurtenbach, M.O. Masuda and A.C. Campos de Carvalho (2003) Human chagasic IgGs bind to cardiac muscarinic receptors and impair L-type Ca2+ currents. Cardiovasc. Res. 58 55-65.
79. A. Hocevar, M. Tomsic, S. Praprotnik, M. Hojnik, T. Kveder and B. Rozman (2003) Parasympathetic nervous system dysfunction in primary Sjogren's syndrome. Ann. Rheum. Dis. 62 702-704.
80. W. Hoch, J. McConville, S. Helms, J. Newsom-Davis, A. Melms and A. Vincent (2001) Auto-antibodies to the receptor tyrosine kinase muSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7 365-368.
81. G.H. Hockerman, B.Z. Peterson, B.D. Johnson and W.A. Catterall (1997) Molecular determinants of drug binding and action on L-type calcium channels. Annu. Rev. Pharmacol. Toxicol. 37 361-396.
82. H. Houzen, Y. Hattori, M. Kanno, S. Kikuchi, K. Tashiro, M. Motomura, Y. Nakao and T. Nakamura (1998) Functional evaluation of inhibition of autonomic trassmitter release by autoantibody from Lambert-Eaton myasthenic syndrome. Ann. Neurol. 43 677-680.
83. E.C. Hulme, Z.L. Lu, J.W. Saldanha and M.S. Bee (2003) Structure and activation of muscarinic acetylcholine receptors. Biochem. Soc. Trans. 31 29-34.
84. M. Iwata, T. Yoshikawa, A. Baba, T. Anzai, I. Nakamura, Y. Wainai, T. Takahashi and S. Ogawa (2001) Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ. Res. 88 578-586.
85. M.W. Jackson, T.P. Gordon and S.A. Waterman (2004) Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology 126 819-828.
86. R. Jahns, V. Boivin, C. Siegmund, G. Inselmann, M.J. Lohse and F. Boege (1999) Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 99 649-654.
87. S.W. Jones (1998) Overview of voltage-dependent calcium channels. J. Biocnergetics Biomembranes 30 299-312.
88. M.D. Kazatchkine and S. Kaveri (2001) Immunomodulation of auto-immune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 345 747-755.
89. J. Kelemen, W. Hedlund, J.B. Orlin, E.M. Berkman and T.L. Munsat (1983) Plasmapheresis with immunosuppression in amyotrophic lateral sclerosis. Arch. Neurol. 40 752-753.
90. E.H. Kemp, E.A. Waterman, B.E. Hawes, K. O'Neill, R.V. Gottumukkala, D.J. Gawkrodger, A.P. Weetman and P.F. Watson (2002) The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J. Clin. Invest. 109 923-930.
91. F. Kimura, R.G. Smith, O. Delbono, O. Nyormoi, T. Schneider, W. Nastainczyk, F. Hofmann, E. Stefani and S.H. Appel (1994) Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit. Ann. Neurol. 35 164-171.
92. C.A. Kirvan, S.E. Swedo, J.S. Heuser and M.W. Cunningham (2003) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat. Med. 9 914-920.
93. C.H. Knowles, B. Lang, L. Clover, S.M. Scott, C. Gotti, A. Vincent and J.E. Martin (2002) A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility. Scand. J. Gastroenterol 37 166-170.
94. K. Komai, K. Iwasa and M. Takamori (1999) Calcium channel peptide can cause an autoimmune-mediated model of Lambert-Eaton myasthenic syndrome in rats. J. Neurol. Sci. 166 126-130.
95. R. La Corte, A. Potena, G. Bajocchi, L. Fabbri and F. Trotta (1991) Increased bronchial responsiveness in primary Sjogren's syndrome. A sign of tracheobronchial involvement. Clin. Exp. Rheumatol. 9 125-130.
96. B. Lang, J. Newsom-Davis, C. Peers, C. Prior and D.W. Wray (1987) The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J. Physiol. 390 257-270.
97. B. Lang, J. Newsom-Davis, C. Prior and D. Wray (1983) Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J. Physiol. 344 335-345.
98. B. Lang, B. Williams, I. Bernudez, H. Cross, E. Hughes, S. Wroe, Y. Hart, A. Vincent and J. Palace (2001) Autoantibodies in idiopathic forms of epilepsy (abstract). J. Neuroimmunol. 118 145.
99. D. Le Guludec, A. Cohen-Solal, J. Delforge, N. Delahaye, A. Syrota and P. Merlet (1997) Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy: an in vivo PET study. Circulation 96 3416-3422.
100. E.K. Lee, R.A. Maselli, W.G. Ellis and M.A. Agius (1998) Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma. J. Neurol. Neurosurg. Psychiatry 65 857-862.
101. C.P. Leiros, L. Sterin-Borda, E.S. Borda, J.C. Goin and M.M. Hosey (1997) Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by antoantibodies from patients with Chagas' disease. J. Biol. Chem. 272 12989-12993.
102. V.A. Lennon, L.G. Ermilov, J.H. Szurszewski and S. Vernino (2003) Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J. Clin. Invest. 111 907-913.
103. V.A. Lennon, J.M. Lindstrom and M.E. Seybold (1975) Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs. J. Exp. Med. 141 1365-1375.
104. M. Leppilahti, T.L. Tammela, H. Huhtala, P. Kiiholma, K. Leppilahti and A. Auvinen (2003) Interstitial cystitis-like urinary symptoms among patients with Sjogren's syndrome: a population-based study in Finland. Am. J. Med. 115 62-65.
105. M.H. Lessof, H.J. Crawford and R.M. Wood (1959) Antibody to thyroglobulin in patients with thyroid disease. Lancet 2 1172-1173.
106. M. Levite, I.A. Fleidervish, A. Schwarz, D. Pelled and A.H. Futerman (1999) Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J. Autoimmun. 13 61-72.
107. M. Levite and A. Hermelin (1999) Autoimmunity to the glutamate receptor in mice—a model for Rasmussen's encephalitis? J. Autoimmun. 13 73-82.
108. K. Leys, B. Lang, A. Vincent and J. Newsom-Davis (1989) Calcium channel antoantibodies in Lambert-Eaton myasthenic syndrome. Lancet 2 1107.
109. Y.H. Liao, Y.M. Wei, M. Wang, Z.H. Wang, H.T. Yuan and L.X. Cheng (2002) Antoantibodies against AT1-receptor and alphal-adrenergic receptor in patients with hypertension. Hypertens. Res. 25 641-646.
110. R. Liguori, A. Vincent, L. Clover, P. Avoni, G. Plazzi, P. Cortelli, A. Baruzzi, T. Carey, P. Gambetti, E. Lugaresi and P. Montagna (2001) Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124 2417-2426.
111. C.J. Limas, I.F. Goldenberg and C. Limas (1991) Effect of antireceptor antibodies in dilated cardiomyopathy on the cycling of cardiac beta receptors. Am. Heart J. 122 108-114.
112. J. Lindstrom, B. Einarson and J. Merlie (1978) Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle. Proc. Natl. Acad. Sci. USA 75 769-773.
113. J.M. Lindstrom, M.E. Seybold, V.A. Lennon, S. Whittingham and D.D. Duane (1976) Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates and diagnostic value. Neurology 26 1054-1059.
114. R. Llinas, M. Sugimori, B.D. Cherksey, R.G. Smith, O. Delbono, E. Stefani and S. Appel (1993) IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer. Proc. Natl. Acad. Sci. USA 90 11743-11747.
115. D. Ludviksdottir, C. Janson, E. Bjornsson, G. Stalenheim, G. Boman, H. Hedenstrom, P. Venge, B. Gudbjornsson and S. Valtysdottir (2000) Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjogren's syndrome. BHR Study Group. Bronchial hyperresponsiveness. Allergy 55 259-265.
116. H.P. Luther, V. Homuth and G. Wallukat (1997) Alpha 1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension 29 678-682.
117. A. Madrid, A. Gil-Peralta, E. Gil-Neciga, J.R. Gonzalez and S. Jarrin (1996) Morvan's fibrillary chorea: remission after plasmapheresis. J. Neurol. 243 350-353.
118. Y. Magnusson, G. Wallukat, F. Waagstein, A. Hjalmarson and J. Hoebeke (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 89 2760-2767.
119. R. Mantegazza, P. Bernasconi, F. Baggi, R. Spreafico, F. Ragona, C. Antozzi, G. Bernardi and T. Granata The Italian Rasmussen's Encephalitis Study Group (2002) Antibodies agaist GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J. Neuroimmunol. 131 179-185.
120. S. Marion, J.M. Braun, A. Ropars, L.D. Kohn and J. Charreire (1994) Induction of autoimmunity by immunization of mice with human thyrotropin receptor. Cell. Immunol. 158 329-341.
121. W.P. Mason, F. Graus, B. Lang, J. Honnorat, J.Y. Delattre, F. Valldeoriola, J.C. Antoine, M.K. Rosenblum, M.R. Rosenfeld, J. Newsom-Davis, J.B. Posner and J. Dalmau (1997) Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 120 1279-1300.
122. M.O. Masuda, M. Levin, S.F. De Oliveira, P.C. Dos Santos Costa, P.L. Bergami, N.A. Dos Santos Almeida, R.C. Pedrosa, I. Ferrari, J. Hoebeke and A.C. Campos de Carvalho (1998) Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens. FASEB J. 12 1551-1558.
123. S. Matsui, M.L. Fu, M. Hayase, S. Katsuda, N. Yamaguchi, K. Teraoka, T. Kurihara and N. Takekoshi (1999) Active immunization of combined betal-adrenoceptor and M2-muscarinic receptor peptides induces cardiac hypertrophy in rabbits. J. Card. Failure 5 246-254.
124. S. Matsui, M.L. Fu, S. Katsuda, M. Hayase, N. Yamaguchi, K. Teraoka, T. Kurihara, N. Takekoshi, E. Murakami, J. Hoebeke and A. Hjalmarson (1997) Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J. Mol. Cell. Cardiol. 29 641-655.
125. S. Matsui, M.L. Fu, M. Shimizu, T. Fukuoka, K. Teraoka, N. Takekoshi, E. Murakami and A. Hjalmarson (1995) Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors. Autoimmunity 21 85-88.
126. P.A. McCombe, R. Wilson and R.L. Prentice (1992) Anti-ganglioside antibodies in peripheral neuropathy. Clin. Exp. Neurol. 29 182-188.
127. S.M. McLachlan and B. Rapoport (1996) Monoclonal human autoantibodies to the TSH receptor—The holy grail and why are we looking for it? J. Clin. Endocrinol. Metab. 81 3152-3154.
128. S.D. Meriney, S.C. Hulsizer, V.A. Lennon and A.D. Grinnell (1996) Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Ann. Neurol. 40 739-749.
129. N. Meucci, E. Nobile-Orazio and G. Scarlato (1996) Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis. J. Neurol. 243 117-120.
130. M.D. Mignogna, S. Fedele, L. Lo Russo and L. Lo Muzio (2003) Sialorrhoea as early oral clinical manifestation of primary Sjogren's syndrome? Rheumatology (Oxford) 42 1113-1114.
131. A. Mijares, D. Lebesgue, G. Wallukat and J. Hoebeke (2000) From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists. Mol. Pharmacol. 58 373-379.
132. M. Motomura (1999) The Lambert-Eaton myasthenic syndrome: a study of 100 Japanese cases. Rinsho Shinkeigaku 39 1237-1239.
133. M. Motomura, B. Lang, I. Johnston, J. Palace, A. Vincent and J. Newsom-Davis (1997) Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J. Neurol. Sci. 147 35-42.
134. J.N. Muth, G. Varadi and A. Schwartz (2001) Use of transgenic mice to study voltage-dependent Ca2+ channels. Trends Pharmacol. Sci. 22 526-532.
135. J. Newsom-Davis (1997) Antoantibody-mediated channelopathies at the neuromuscular junction. Prog. Clin. Neurosci. 3 337-346.
136. J. Newsom-Davis (1997) Autoimmune neuromyotonia (Isaacs' syndrome): an antibody-mediated potassium channelopathy. Ann. N. Y. Acad. Sci. 835 111-119.
137. J. Newsom-Davis, A.J. Pinching, A. Vincent and S.G. Wilson (1978) Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 28 266-272.
138. K.H. Nguyen, J. Brayer, S. Cha, S. Diggs, U. Yasunari, G. Hilal, A.B. Peck and M.G. Humphreys-Beher (2000) Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum. 43 2297-2306.
139. D. Offen, S. Halevi, D. Orion, R. Mosberg, H. Stern-Goldberg, E. Melamed and D. Atlas (1998) Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels. Neurology 51 1100-1103.
140. M. Ohlsson, T.P. Gordon and S.A. Waterman (2002) Role of anti-calcium channel and anti-receptor autoantibodies in autonomic dysfunction in Sjogren's syndrome. J. Neuroimmunol. 127 127-133.
141. M. Ohmori, T. Endo, M. Ikedo and T. Onaya (1992) Immunization with human thyrotrophin receptor peptide induces an increase in thyroid hormone in rabbits. J. Endocrinol. 135 479-484.
142. T. Okazaki, Y. Tanaka, R. Nishio, T. Mitsuiye, A. Mizoguchi, J. Wang, M. Ishida, H. Hiai, A. Matsumori, N. Minato and T. Honjo (2003) Antoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med. 9 1477-1483.
143. J.H. O'Neill, N.M. Murray and J. Newsom Davis (1988) The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111 577-596.
144. T.J. O'Shaughnessy, H. Yan, J. Kim, E.H. Middlekauff, K.W. Lee, L.H. Phillips and Y.I. Kim (1998) Amyotrophic lateral sclerosis: serum factors enhance spontaneous and evoked transmitter release at the neuromuscular junction. Muscle Nerve 21 81-90.
145. Z. Pan, C.J. Anderson and H.A. Stafford (1998) Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults. J. Clin. Invest. 102 215-222.
146. J. Patrick and J. Lindstrom (1973) Autoimmune response to acetylcholine receptor. Science 180 871-872.
147. C. Peers, I. Johnston, B. Lang and D. Wray (1993) Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction. Neurosci. Lett. 153 45-48.
148. C. Peers, B. Lang, J. Newsom-Davis and D.W. Wray (1990) Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma × glioma cell line. J. Physiol. 421 293-308.
149. C. Perez Leiros, N. Goren, L. Sterin-Borda, L. Lustig and E. Borda (1994) Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies. Clin. Auton. Res. 4 249-255.
150. C. Perez Leiros, L. Sterin-Borda, O. Hubscher, R. Arana and E.S. Borda (1999) Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjogren syndrome antibodies. Clin. Immunol. 90 190-195.
151. A. Pinto, K. Iwasa, C. Newland, J. Newsom-Davis and B. Lang (2002) The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels. Muscle Nerve 25 715-724.
152. S. Podlowski, H.P. Luther, R. Morwinski, J. Muller and G. Wallukat (1998) Agonistic anti-betal-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the betal-adrenergic receptor expression in neonatal rat cardiomyocytes. Circulation 98 2470-2476.
153. P. Pozo-Rosich, L. Clover, A. Saiz, A. Vincent and F. Graus (2003) Voltage-gated potassium channel antibodies in limbic encephalitis. Ann. Neurol. 54 530-533.
154. R. Press, S. Mata, F. Lolli, J. Zhu, T. Andersson and H. Link (2001) Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome. J. Neurol. Sci. 190 41-47.
155. C. Prior, B. Lang, D. Wray and J. Newsom-Davis (1985) Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals. Ann. Neurol. 17 587-592.
156. Y. Qu, G.Q. Xiao, L. Chen and M. Boutjdir (2001) Autoantibodies from mothers of children with congenital heart block downregulate cardiac L-type Ca channels. J. Mol. Cell. Cardiol. 33 1153-1163.
157. A. Roberts, S. Perera, B. Lang, A. Vincent and J. Newsom-Davis (1985) Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature 317 737-739.
158. M. Roberts, H. Willison, A. Vincent and J. Newsom-Davis (1994) Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 343 454-455.
159. C.P. Robinson, J. Brayer, S. Yamachika, T.R. Esch, A.B. Peck, C.A. Stewart, E. Peen, R. Jonsson and M.G. Humphreys-Beher (1998) Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjogren's syndrome. Proc. Natl. Acad. Sci. USA 95 7538-7543.
160. S.W. Rogers, P.I. Andrews, L.C. Gahring, T. Whisenand, K. Cauley, B. Crain, T.E. Hughes, S.F. Heinemann and J.O. McNamara (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265 648-651.
161. A. Rosztoczy, L. Kovacs, T. Wittmann, J. Lonovics and G. Pokorny (2001) Manometric assessment of impaired esophageal motor function in primary Sjogren's syndrome. Clin. Exp. Rheumatol. 19 147-152.
162. D.B. Sanders, K. El-Salem, J.M. Massey, J. McConville and A. Vincent (2003) Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60 1978-1980.
163. J.M. Schott, K. Harkness, J. Barnes, A.I. della Rocchetta, A. Vincent and M.N. Rossor (2003) Amnesia, cerebral atrophy, and autoimmunity. Lancet 361 1266.
164. B. Schwerer (2002) Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome. Microbes Infect. 4 373-384.
165. P. Shillito, P.C. Molenaar, A. Vincent, K. Leys, W. Zheng, R.J. van den Berg, J.J. Plomp, G.T.H. Van Kempen, G. Chauplannaz, A.R. Wintzen, J.G. van Dijk and J. Newsom-Davis (1995) Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann. Neurol. 38 714-722.
166. P. Sillevis Smitt, A. Kinoshita, B. De Leeuw, W. Moll, M. Coesmans, D. Jaarsma, S. Henzen-Logmans, C. Vecht, C. De Zeeuw, N. Sekiyama, S. Nakanishi and R. Shigemoto (2000) Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N. Engl. J. Med. 342 21-27.
167. S. Sinha, J. Newsom-Davis, K. Mills, N. Byrne, B. Lang and A. Vincent (1991) Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 338 75-77.
168. C.U.M. Smith (1996) Elements of Molecular Neurobiology Chichester: John Wiley
169. R.G. Smith, M.E. Alexianu, G. Crawford, O. Nyormoi, E. Stefani and S.H. Appel (1994) Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc. Natl. Acad. Sci. USA 91 3393-3397.
170. C. Solaro, R. Mantegazza, E. Capello, M. Cilli, U. Cardellino, D. Giunti, L. Roccatagliata, B. Giometto, G.L. Mancardi and A. Uccelli (2001) Cerebral GvHD in a patient with Anti-GluR3 antibodies: a passive transfer study (abstract). J. Neuroimmunol. 118 147.
171. A. Staudt, R. Mobini, M. Fu, Y. Grosse, V. Stangl, K. Stangl, A. Thiele, G. Baumann and S.B. Felix (2001) Beta(1)-adrenoceptor antibodies induce positive inotropic response in isolated cardiomyocytes. Eur. J. Pharmacol. 423 115-119.
172. L. Sterin-Borda and E. Borda (2000) Role of neurotransmitter autoantibodies in the pathogenesis of chagasic peripheral dysautonomia. Ann. N. Y. Acad. Sci. 917 273-280.
173. R. Sterz, R. Hohlfeld, K. Rajki, M. Kaul, K. Heininger and K. Peper (1986) Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab′)2 hybrid molecules. Muscle Nerve 9 306-312.
174. J. Striessnig (1999) Pharmacology, structure and function of cardiac L-type Ca2+ channels. Cell Physiol. Biochem. 9 242-269.
175. I. Sutton and J.B. Winer (2002) The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci (Lond.) 102 475-486.
176. S.E. Swedo (1994) Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA 272 1788-1791.
177. M.M. Thomas and S.M. Dunn (1997) Amyotrophic lateral sclerosis immunoglobulins are ineffective in altering calcium influx through presynaptic voltage-sensitive calcium channels. Neurol. Res. 19 129-134.
178. K.V. Toyka, D.B. Drachman, D.E. Griffin, A. Pestronk, J.A. Winkelstein, K.H. Fishbeck and I. Kao (1977) Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N. Engl. J. Med. 296 125-131.
179. E.B. Tsianos, C.D. Chiras, A.A. Drosos and H.M. Moutsopoulos (1985) Oesophageal dysfunction in patients with primary Sjögren's syndrome. Ann. Rheum. Dis. 44 610-613.
180. R.E. Twyman, L.C. Gahring, J. Spiess and S.W. Rogers (1995) Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 14 755-762.
181. O.D. Uchitel, S.H. Appel, F. Crawford and L. Sczcupak (1988) Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals. Proc. Natl. Acad. Sci. USA 85 7371-7374.
182. O.D. Uchitel, F. Scornik, D.A. Protti, C.G. Fumberg, V. Alvarez and S.H. Appel (1992) Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins. Neurology 42 2175-2180.
183. S. Vernino, J. Adamski, T.J. Kryzer, R.D. Fealey and V.A. Lennon (1998) Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50 1806-1813.
184. S. Vernino, W.P. Cheshire and V.A. Lennon (2001) Myasthenia gravis with autoimmune autonomic neuropathy. Auton. Neurosci. 88 187-192.
185. S. Vernino and V.A. Lennon (2002) Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 26 702-707.
186. S. Vernino, P.A. Low, R.D. Fealey, J.D. Stewart, G. Farrugia and V.A. Lennon (2000) Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 343 847-855.
187. S. Vernino, L.G. Ermilov, L. Sha, J.H. Szurszewski, P.A. Low and V.A. Lennon (2004) Passive transfer of autoimmune autonomic neuropathy to mice. J. Neurosci. 24 7037-7042.
188. M.P. Viglione, J.K. Blandino, S.J. Kim and Y.I. Kim (1993) Effects of Lambert-Eaton syndrome serum and IgG on calcium and sodium currents in small-cell lung cancer cells. Ann. N. Y. Acad. Sci. 681 418-421.
189. M.P. Viglione, C. Creutz and Y.I. Kim (1992) Lambert-Eaton syndrome: antigen-antibody interaction and calcium current inhibition in chromaffin cells. Muscle Nerve 15 1325-1333.
190. M.P. Viglione, T.J. O'Shaughnessy and Y.I. Kim (1995) Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. J. Physiol. (Lond.) 488 303-317.
191. F. Villani, R. Spreafico, L. Farina, A.R. Giovagnoli, P. Bernasconi, T. Granata and G. Avanzini (2001) Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology 56 248-250.
192. A. Vincent (2002) Measuring and evaluating the significance of autoantibodies in neurological disorders. Clin. Appl. Immunol. Rev. 3 127-151.
193. A. Vincent (2004) Encephalitis lethargica: part of a spectrum of post-streptococcal autoimmune diseases? Brain 127 2-3.
194. A. Vincent, C. Buckley, J.M. Schott, I. Baker, B.K. Dewar, N. Detert, L. Clover, A. Parkinson, C.G. Bien, S. Omer, B. Lang, M.N. Rossor and J. Palace (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127 701-712.
195. A. Vincent, O. Lily and J. Palace (1999) Pathogenic autoantibodies to neuronal proteins in neurologica disorders. J. Neuroimmunol. 100 169-180.
196. J. Walker, T. Gordon, S. Lester, S. Downie-Doyle, D. McEvoy, K. Pile, S. Waterman and M. Rischmueller (2003) Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome. J. Rheumatol. 30 2406-2412.
197. G. Wallukat, H.M. Fu, S. Matsui, A. Hjalmarson and M.L. Fu (1999) Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects. Life Sci. 64 465-469.
198. G. Wallukat, V. Homuth, T. Fischer, C. Lindschau, B. Horstkamp, A. Jupner, E. Baur, E. Nissen, K. Vetter, D. Neichel, J.W. Dudenhausen, H. Haller and F.C. Luft (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 103 945-952.
199. G. Wallukat, J. Muller, S. Podlowski, E. Nissen, R. Morwinski and R. Hetzer (1999) Agonist-like beta-adrenoceptor antibodies in heart failure. Am. J. Cardiol. 83 75H-79H.
200. G. Wallukat, A. Wollenberger, R. Morwinski and H.F. Pitschner (1995) Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. J. Mol. Cell. Cardiol. 27 397-406.
201. S.A. Waterman, T.P. Gordon and M. Rischmueller (2000) Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum. 43 1647-1654.
202. S.A. Waterman, B. Lang and J. Newsom-Davis (1997) Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann. Neurol. 42 147-156.
203. K.D. Whitney, P.I. Andrews and J.O. McNamara (1999) Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis. Neurology 53 699-708.
204. H. Wiendl, C.G. Bien, P. Bernasconi, B. Fleckenstein, C.E. Elger, J. Dichgans, R. Mantegazza and A. Melms (2001) GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 57 1511-1514.
205. G. Williams, N. Peshu, C.I. Newbold, K. Marsh, C.R.J.C. Newton and B. Lang (2001) Autoantibodies against ion channels in children who develop seizures following CNS infection (abstract). J. Neuroimmunol. 118 148.
206. S.J. Wood and C.R. Slater (2001) Safety factor at the neuromuscular junction. Prog. Neurobiol. 64 393-429.
207. G.Q. Xiao, K. Hu and M. Boutjdir (2001) Direct inhibition of expressed cardiac L- and T-type calcium channels by IgG from mothers whose children have congenital heart block. Circulation 103 1599-1604.
208. G.Q. Xiao, Y. Qu, K. Hu and M. Boutjdir (2001) Down-regulation of L-type calcium channel in pups born to 52 kDa SSA/Ro immunized rabbits. FASEB J. 15 1539-1545.
209. Y.F. Xu, S.J. Hewett and W.D. Atchison (1998) Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals. J. Neurophysiol. 80 1056-1069.
210. N. Yuki, C.W. Ang, M. Koga, B.C. Jacobs, P.A. van Doorn, K. Hirata and F.G. van der Meche (2000) Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside. Ann. Neurol. 47 314-321.
211. N. Yuki and F. Miyagi (1996) Possible mechanism of intravenous immunoglobulin treatment on anti-GM1 antibody-mediated neuropathies. J. Neurol. Sci. 139 160-162.
212. F.Y. Zeng and J. Wess (1999) Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem. 274 19487-19497.
213. A.B. Zhainazarov, P. Annunziata, S. Toneatto, E. Cherubini and A. Nistri (1994) Serum fractions from amyotrophic lateral sclerosis patients depress voltage-activated Ca2+ currents of rat cerebellar granule cells in culture. Neurosci. Lett. 172 111-114.